Clinical Trial Results: Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral atogepant to oral topiramate in adults with migraine, focusing on adverse events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Atogepant (Atogepant)
• Topiramate (Topiramate)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2026-07-02